NCT05793177 MONitoring Sedentary Behavior and Light Physical Activity in Patients With Stroke
| NCT ID | NCT05793177 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zealand University Hospital |
| Condition | Stroke, Acute |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2024-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-10-01 with a primary completion date of 2024-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized control trial (RCT) aims to test the effect of a 12 weeks tailored behavioral intervention on stroke survivors living in the community and compare the results to a control group of stroke survivors participating in standard care. The intervention's purpose is to lower the time spend with sedentary behavior and raise the level of physical activity in stroke survivors throughout their everyday life. The intervention contains two motivational interviews with a focus on goal setting, action planning, motivation, fatigue management, and general information on life after stroke. The primary outcome for behavior change is objectively measured physical activity using an activity tracker (ActivPal4 Micro) and secondary glycohemoglobin and changes in quality of life.
Eligibility Criteria
Inclusion Criteria: * Verified ischemic stroke or intracerebral hemorrhage * Modified rankin score (mRS) 1-3 at discharge * Discharged with at rehabilitation plan within 1-14 hospitalization days * Able to ambulate independently * Speak and understand Danish Exclusion Criteria: * Aphasia * Unable to give informed consent * Unable to ambulate independently * Mental illness * Other co-morbidity like terminal cancer.
Frequently Asked Questions
Who can join the NCT05793177 clinical trial?
This trial is open to participants of all sexes, studying Stroke, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05793177 currently recruiting?
Yes, NCT05793177 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zealand University Hospital to inquire about joining.
Where is the NCT05793177 trial being conducted?
This trial is being conducted at Roskilde, Denmark.
Who is sponsoring the NCT05793177 clinical trial?
NCT05793177 is sponsored by Zealand University Hospital. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.